After finishing at $1.21 in the prior trading day, Aclaris Therapeutics Inc (NASDAQ: ACRS) closed at $1.22, up 0.83%. On the day, 676808 shares were traded.
Ratios:
Our goal is to gain a better understanding of ACRS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.16 and its Current Ratio is at 4.16. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On October 03, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $22.Evercore ISI initiated its Outperform rating on October 03, 2023, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’24 when Powell Andrew Kenneth William bought 6,000 shares for $1.25 per share. The transaction valued at 7,500 led to the insider holds 28,863 shares of the business.
Powell Andrew Kenneth William bought 8,500 shares of ACRS for $10,455 on Mar 01 ’24. The Director now owns 22,863 shares after completing the transaction at $1.23 per share. On Oct 23 ’23, another insider, Monahan Joseph, who serves as the Chief Scientific Officer of the company, sold 6,000 shares for $5.08 each. As a result, the insider received 30,460 and left with 129,724 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.77 while its Price-to-Book (P/B) ratio in mrq is 0.55.
Stock Price History:
Over the past 52 weeks, ACRS has reached a high of $11.12, while it has fallen to a 52-week low of $0.59.
Shares Statistics:
A total of 70.89M shares are outstanding, with a floating share count of 64.47M. Insiders hold about 9.10% of the company’s shares, while institutions hold 89.14% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Axcelis Technologies, Inc. different market analysts. The consensus estimate for the next quarter is $6.52, with high estimates of $77.52 and low estimates of $1.22.
Analysts are recommending an EPS of between $Industrials and $Healthcare for the fiscal current year, implying an average EPS of $Real Estate.
